Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Ambrx Biopharma Inc ADR stock
Learn how to easily invest in Ambrx Biopharma Inc ADR stock.
Ambrx Biopharma Inc ADR is a biotechnology business based in the US. Ambrx Biopharma Inc ADR shares (AMAM) are listed on the NYSE and all prices are listed in US Dollars. Ambrx Biopharma Inc ADR employs 81 staff and has a trailing 12-month revenue of around $5.2 million.
How to buy shares in Ambrx Biopharma Inc ADR
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AMAM – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Ambrx Biopharma Inc ADR stock price (NYSE: AMAM)Use our graph to track the performance of AMAM stocks over time.
Ambrx Biopharma Inc ADR shares at a glance
|Latest market close||$1.07|
|52-week range||$1.02 - $14.82|
|50-day moving average||$2.03|
|200-day moving average||$4.18|
|Wall St. target price||$6.67|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$6.47|
Buy Ambrx Biopharma Inc ADR shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Ambrx Biopharma Inc ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Ambrx Biopharma Inc ADR price performance over time
|1 week (2022-09-20)||-6.14%|
|1 month (2022-08-26)||-43.39%|
|3 months (2022-06-28)||-59.47%|
|6 months (2022-03-28)||-76.48%|
|1 year (2021-09-28)||-92.23%|
|2 years (2020-09-24)||N/A|
|3 years (2019-09-24)||N/A|
|5 years (2017-09-24)||N/A|
Is Ambrx Biopharma Inc ADR stock undervalued or overvalued?
Valuing Ambrx Biopharma Inc ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ambrx Biopharma Inc ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ambrx Biopharma Inc ADR's P/E ratio
Ambrx Biopharma Inc ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Ambrx Biopharma Inc ADR shares trade at around 0x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Ambrx Biopharma Inc ADR's P/E ratio is best considered in relation to those of others within the biotechnology industry or those of similar companies.
Ambrx Biopharma Inc ADR financials
|Revenue TTM||$5.2 million|
|Gross profit TTM||$7.5 million|
|Return on assets TTM||-24.66%|
|Return on equity TTM||-54.12%|
|Market capitalisation||$40.9 million|
TTM: trailing 12 months
Ambrx Biopharma Inc ADR share dividends
We're not expecting Ambrx Biopharma Inc ADR to pay a dividend over the next 12 months.
Ambrx Biopharma Inc ADR overview
Ambrx Biopharma Inc. , a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gastric/gastroesophageal junction cancer, and other solid tumors, including ongoing Phase 2/3 clinical trials for the treatment of HER2-positive metastatic breast cancer and gastric cancer. The company is also developing two earlier-stage product candidates, including ARX517, an anti-PSMA ADC, which is in a Phase 1 clinical trial for the treatment of prostate cancer and other solid tumors; and ARX305, an anti-CD70 ADC in investigational new drug-enabling studies for the treatment of renal cell carcinoma and other cancers. In addition, it is developing other multiple product candidates targeting immuno-oncology applications, which include ARX822, a fab-small molecule bispecific that is in preclinical development for cancers; and ARX102, an immuno-oncology IL-2 pathway agonist to stimulate the patient's own immune system by targeting the ß and gamma receptors on the cytotoxic T cell. Ambrx Biopharma Inc. has collaborations with Bristol Myers Squibb Company; AbbVie Inc.
Frequently asked questionsWhat percentage of Ambrx Biopharma Inc ADR is owned by institutions?
Currently 50.975% of Ambrx Biopharma Inc ADR shares are held by institutions. How many people work for Ambrx Biopharma Inc ADR?
Latest data suggests 81 work at Ambrx Biopharma Inc ADR. When does the fiscal year end for Ambrx Biopharma Inc ADR?
Ambrx Biopharma Inc ADR's fiscal year ends in December. Where is Ambrx Biopharma Inc ADR based?
Ambrx Biopharma Inc ADR's address is: 10975 North Torrey Pines Road, La Jolla, CA, United States, 92037 What is Ambrx Biopharma Inc ADR's ISIN number?
Ambrx Biopharma Inc ADR's international securities identification number is: US02290A1025
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert